Eligible shareholders can, if they wish, increase their shareholding in Barclays through the Programme. Shareholders who join the Programme will receive new ordinary shares in Barclays instead of a cash dividend,without incurring dealing costs or stamp duty.
Legal restrictions apply. Shareholders who are resident outside the UK may participate in the Programme provided that they do not live in nor are subject to the jurisdiction of any country where their participation in the Programme would require Barclays to comply with local legal, governmental or regulatory requirements or procedures, or any similar formalities.
Shareholders resident outside the UK are responsible for ensuring that they may validly participate in the Programme and for observing all relevant formalities.
Scrip reference share price – April 2017 dividend
The Scrip reference share price for the final dividend in respect of the year ended 31 December 2016 was 229.44p. This price was calculated using the average of the closing middle market quotations for ordinary shares, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from Thursday, 2 March 2017 (ex-dividend date) to Wednesday, 8 March 2017 (inclusive).
To participate in or leave the Programme in respect of the April 2017 dividend payment, Equiniti must have received your Scrip Dividend Mandate Form or Revocation Form (as appropriate) no later than 16:30 (UK time) on Friday, 17 March 2017. Any forms received after this date apply to dividends paid thereafter.
Scrip Dividend Programme Terms and Conditions (PDF 127KB, new window)
Scrip Dividend Mandate Form (PDF 189KB, new window)
Scrip Dividend Revocation Form (PDF 188KB, new window)